DOI: https://doi.org/10.22141/2224-0721.15.2.2019.166096

Insulin and leptin levels in type 1 and type 2 diabetes patients with diabetes-associated osteoarthritis

V.L. Orlenko, M.D. Tronko, O.T. Yelizarova

Abstract


Background. Joint damage in patients with diabetes mellitus is a common complication and is associated with degenerative dystrophic changes in the periarticular structures. The purpose of our work was to study insulin and leptin hormone levels in patients with diabetic osteoarthritis and to investigate their possible influence on the development of this complication. Materials and methods. Seventy­seven patients were examined, they were divided into groups by the type of diabetes mellitus, the presence and severity of diabetic arthropathy. The content of insulin and leptin in the blood serum was determined by enzyme­linked immunosorbent assay. Results. Diabetic arthropathy was diagnosed in more than 70 % of patients. In persons with diabetic arthropathy, insulin levels were significantly elevated (for type 1 diabetes mellitus — by 38.5 %, for type 2 diabetes mellitus — by 55.6 %), as well as leptin content (for type 1 diabetes mellitus — by 43.8 %, for type 2 diabetes mellitus — by 53.7 %). There is a direct correlation between the severity of joint damage and the levels of insulin and leptin. The severity of arthropathy in patients with type 2 diabetes mellitus directly correlates with insulin resistance. Conclusions. Risk of developing arthropathy in type 1 diabetes mellitus with elevated insulin levels is increased by 3.8 times, with elevated leptin content — by 1.3 times, in patients with type 2 diabetes mellitus — by 2.6 and 1.2 times, respectively. For this sample, it was found that the development of arthropathy does not depend on the type of diabetes mellitus. In women with type 2 diabetes, the risk of developing arthropathy is 6.4­time higher than in men. Thus, an increased insulin and leptin levels can be markers of the presence and progression of arthropathy in patients with diabetes mellitus.


Keywords


diabetes mellitus; diabetic arthropathy; joints; chondrocytes; insulin; leptin

References


Majjad Y, Errahali H, Toufik JH, Djossou MA, et al. Musculoskeletal disorders in patients with Diabetes Mellitus: A Cross-Sectional Study. Int J Rheum. 2018;2018:3839872. doi: 10.1155/2018/3839872.

Larkin ME, Barnie A, Braffett BH, et al. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37(7):1863-1869. doi: 10.2337/dc13-2361.

Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis. 2011 Aug;70(8):1354-6. doi: 10.1136/ard.2010.146399.

Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A, Simopoulos C. Human leptin induces angiogenesis in vivo. Cytokine. 2008 Jun;42(3):353-7. doi: 10.1016/j.cyto.2008.03.009.

Upadhyay J, Farr OM, Mantzoros CS. The role of leptin in regulating bone metabolism. Metabolism. 2015 Jan;64(1):105-13. doi: 10.1016/j.metabol.2014.10.021.

Simopoulou T, Malizos KN, Iliopoulos D, et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage. 2007 Aug;15(8):872-83. doi: 10.1016/j.joca.2007.01.018.

Kraus VB, Stabler TV, Luta G, Renner JB, Dragomir AD, Jordan JM. Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. Osteoarthritis Cartilage. 2007 Aug;15(8):966-71. doi: 10.1016/j.joca.2007.02.014.

Scully SP, Lee JW, Ghert PMA, Qi W. The role of the extracellular matrix in chondrocyte regulation. Clin Orthop Relat Res. 2001 Oct;(391 Suppl):S72-89.

Fan Z, Chubinskaya S, Rueger DC, Bau B, Haag J, Aigner T. Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin Exp Rheumatol. 2004 Jan-Feb;22(1):103-6.

Figenschau Y, Knutsen G, Shahazeydi S. et al. Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun. 2001 Sep 14;287(1):190-7. doi: 10.1006/bbrc.2001.5543.

Takeda S, Elefteriou F, Levasseur R. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002 Nov 1;111(3):305-17.

Whitfield JF. Leptin: brains and bones. Expert Opin Investig Drugs. 2001 Sep;10(9):1617-22. doi: 10.1517/13543784.10.9.1617.

Kume K, Satomura K, Nishisho S, et al. Potential role of leptin in endochondral ossification. J Histochem Cytochem. 2002 Feb;50(2):159-69. doi: 10.1177/002215540205000204.

Yan M, Zhang J, Yang H, Sun Ye. The role of leptin in osteoarthritis. Medicine (Baltimore). 2018;97(14):e0257. doi: 10.1097/MD.0000000000010257.

Hamrick MW, Herberg S, Arounleut P, et al. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun. 2010 Sep 24;400(3):379-83. doi: 10.1016/j.bbrc.2010.08.079.

Louati K, Vidal C, Berenbaum F, Sellam J. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open. 2015 Jun 2;1(1):e000077. doi: 10.1136/rmdopen-2015-000077.

King KB, Rosenthal AK. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthritis Cartilage. 2015 Jun;23(6):841-50. doi: 10.1016/j.joca.2015.03.031.

Larkin ME, Barnie A, Braffett BH, et al. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014 Jul;37(7):1863-9. doi: 10.2337/dc13-2361.

Rosenbloom A. Periarticular Hand Joint Limitation Syndromes in Diabetes. Endocr Pract. 2014 Aug;20(8):839-42. doi: 10.4158/EP14102.CO.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта